Search for: "Warner-Lambert Company" Results 181 - 200 of 217
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Apr 2015, 7:31 am
| EPO Administrative Council and Board of Appeal’s removal.Never too late 36 [week ending Sunday 8 March] - EPO's Enlarged Board of Appeal (EBA) says Chairman can disobey | OHIM is too rich to be true | eLAW’s TM infringement checklist | Human right and IP | Again on Warner-Lambert v Actavis | Seiko and Seiki in Singapore | The politics of US patent law reform | Haribo v Lindt Goldbear wars | Patent trolls | Private copying | Wu-Tank and… [read post]
26 Jun 2015, 12:30 am
 The main claim at issue is a Swiss form claim, and although this is significant for the present case, much less turns on it than in the other saga ongoing at the moment of Warner Lambert v Actavis (latest instalment here). [read post]
31 Mar 2018, 8:30 am
Strong brands as a barrier to entry, this time from "The Economist" | UK IPO publishes consultation on implementing Trade Mark Directive 2015 into UK law | Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle | EPO looking for new legally qualified members of the Boards of Appeal | Repair or reconstruction: Where do you draw the line for exhaustion under patent law? [read post]
Fig. 3: Plausibility reaches the UK Supreme Court in Warner-Lambert Company LLC v Generics (UK) Ltd While Warner Lambert was a decision made in the context of a second medical use claim, this Case Law was soon also applied to product claims in the UK. [read post]
25 Jan 2009, 2:36 pm
McKinnell, while being groomed as CEO in 2001, was instrumental in Pfizer's $115 billion acquisition of Warner- Lambert Co., the developer of Lipitor. [read post]
6 Mar 2008, 11:14 am
With the Court’s recent ruling in Warner-Lambert affirming the judgment by an equally divided vote, it marked the second time this term that a recusal - of Chief Justice Roberts in this case - had prevented the Justices from issuing an opinion on the merits. [read post]
2 Feb 2015, 2:20 am
 ******************************PREVIOUSLY, ON NEVER TOO LATENever too late 30 [week ending Sunday 18 January] -- Julia Reda’s EU copyright revolution | GC on trade-marketing bottle shapes in (T-69/14 and T-70/14) | IPKat and BLACA’s event on Sensory copyright | IP Cross-Border Enforcement | US Supreme Court in Teva v Sandoz | On-line copyright infringement in Spain | GC on the ‘Pianissimo’ trade mark for vacuum cleaners in Case… [read post]
12 Dec 2008, 6:21 am
Warner-Lambert, n3 the Federal Circuit referred to Elkay Mfg. [read post]
29 Oct 2018, 2:00 am by Matrix Legal Support Service
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
6 Sep 2010, 10:21 am by Steve McConnell
Warner-Lambert & Co., 467 F.3d 85 (2d Cir. 2006), aff'd by equally divided court, 552 U.S. 440 (2008). [read post]
26 Dec 2007, 8:05 am
Perhaps a favorable decision in Warner-Lambert v. [read post]
14 Nov 2010, 5:57 am by Lawrence B. Ebert
The first consumer product was launched in the late 90s and the brand sold to Pfizer-owned Warner-Lambert in 2004. [read post]
15 May 2009, 1:03 am
Pfizer Again Beats Back Class Certification Motion in Consumer Fraud Case The American Lawyer Shortly after Pfizer predecessor Warner-Lambert agreed to pay more than $430 million to resolve criminal charges and civil liabilities for promoting off-label uses for its epilepsy drug Neurontin in 2004, plaintiffs lawyers sought to represent a nationwide class of consumers and third-party payers against the pharmaceutical giant, demanding more than $4 billion… [read post]
22 Aug 2011, 10:08 pm by Steve Bainbridge
Dennis Kozlowski from an academic building in 2005, after the conviction of the former Tyco chief executive for looting his company. [read post]
12 Feb 2008, 8:29 am
Kent case shows how reluctant courts can be to admit that §337(a) means what it says (in Farm Raised Salmon, the pending Warner-Lambert v. [read post]
10 Sep 2012, 2:07 pm by John J. Sullivan
Warner-Lambert & Co., 467 F.3d 85, 94 (2d Cir. 2006)). [read post]
4 Nov 2010, 1:38 pm by Rebecca Tushnet
Warner-Lambert ultimately pled guilty to criminal violations of the FDCA for its off-label marketing and paid civil fines and criminal penalties totaling $430 million. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid:… [read post]